Blood lead of intravenous drug users

Robert Norton, Brent T. Burton, Joseph McGirr

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: A common method of illegal methamphetamine production uses lead acetate as a reagent. Production errors may result in methamphetamine grossly contaminated with lead. Three reports have documented outbreaks of acute lead poisoning in intravenous methamphetamine users. Methods: This study measured blood lead concentrations in intravenous drug users of methamphetamine, cocaine or heroin presenting to the emergency department to determine the prevalence of subclinical lead poisoning in intravenous methamphetamine users. Results: Mean blood leads for methamphetamine users (n = 92) were 6.22 μ g/dL or 0.30 μ mollL (range 0.10-1.15, SD 0.20) and 7.5μ g/dL or 0.35 μ nol/L (0.10-0.80, SD 0.15) for the nonmethamphetamine users (n = 53) with no significant difference between groups. Conclusions: The data suggest that previous outbreaks of acute intravenous lead poisoning among methamphetamine users were probably related to episodic contamination of methamphetamine. Subclinical lead poisoning was not found among the methamphetamine users presenting to the emergency department.

Original languageEnglish (US)
Pages (from-to)425-430
Number of pages6
JournalClinical Toxicology
Volume34
Issue number4
DOIs
StatePublished - 1996

Fingerprint

Methamphetamine
Drug Users
Blood
Industrial poisons
Lead Poisoning
Pharmaceutical Preparations
Disease Outbreaks
Hospital Emergency Service
Heroin
Cocaine
Contamination

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Norton, R., Burton, B. T., & McGirr, J. (1996). Blood lead of intravenous drug users. Clinical Toxicology, 34(4), 425-430. https://doi.org/10.3109/15563659609013813

Blood lead of intravenous drug users. / Norton, Robert; Burton, Brent T.; McGirr, Joseph.

In: Clinical Toxicology, Vol. 34, No. 4, 1996, p. 425-430.

Research output: Contribution to journalArticle

Norton, R, Burton, BT & McGirr, J 1996, 'Blood lead of intravenous drug users', Clinical Toxicology, vol. 34, no. 4, pp. 425-430. https://doi.org/10.3109/15563659609013813
Norton, Robert ; Burton, Brent T. ; McGirr, Joseph. / Blood lead of intravenous drug users. In: Clinical Toxicology. 1996 ; Vol. 34, No. 4. pp. 425-430.
@article{035ab9d70f2941888cbc79db2aa4982e,
title = "Blood lead of intravenous drug users",
abstract = "Objective: A common method of illegal methamphetamine production uses lead acetate as a reagent. Production errors may result in methamphetamine grossly contaminated with lead. Three reports have documented outbreaks of acute lead poisoning in intravenous methamphetamine users. Methods: This study measured blood lead concentrations in intravenous drug users of methamphetamine, cocaine or heroin presenting to the emergency department to determine the prevalence of subclinical lead poisoning in intravenous methamphetamine users. Results: Mean blood leads for methamphetamine users (n = 92) were 6.22 μ g/dL or 0.30 μ mollL (range 0.10-1.15, SD 0.20) and 7.5μ g/dL or 0.35 μ nol/L (0.10-0.80, SD 0.15) for the nonmethamphetamine users (n = 53) with no significant difference between groups. Conclusions: The data suggest that previous outbreaks of acute intravenous lead poisoning among methamphetamine users were probably related to episodic contamination of methamphetamine. Subclinical lead poisoning was not found among the methamphetamine users presenting to the emergency department.",
author = "Robert Norton and Burton, {Brent T.} and Joseph McGirr",
year = "1996",
doi = "10.3109/15563659609013813",
language = "English (US)",
volume = "34",
pages = "425--430",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Blood lead of intravenous drug users

AU - Norton, Robert

AU - Burton, Brent T.

AU - McGirr, Joseph

PY - 1996

Y1 - 1996

N2 - Objective: A common method of illegal methamphetamine production uses lead acetate as a reagent. Production errors may result in methamphetamine grossly contaminated with lead. Three reports have documented outbreaks of acute lead poisoning in intravenous methamphetamine users. Methods: This study measured blood lead concentrations in intravenous drug users of methamphetamine, cocaine or heroin presenting to the emergency department to determine the prevalence of subclinical lead poisoning in intravenous methamphetamine users. Results: Mean blood leads for methamphetamine users (n = 92) were 6.22 μ g/dL or 0.30 μ mollL (range 0.10-1.15, SD 0.20) and 7.5μ g/dL or 0.35 μ nol/L (0.10-0.80, SD 0.15) for the nonmethamphetamine users (n = 53) with no significant difference between groups. Conclusions: The data suggest that previous outbreaks of acute intravenous lead poisoning among methamphetamine users were probably related to episodic contamination of methamphetamine. Subclinical lead poisoning was not found among the methamphetamine users presenting to the emergency department.

AB - Objective: A common method of illegal methamphetamine production uses lead acetate as a reagent. Production errors may result in methamphetamine grossly contaminated with lead. Three reports have documented outbreaks of acute lead poisoning in intravenous methamphetamine users. Methods: This study measured blood lead concentrations in intravenous drug users of methamphetamine, cocaine or heroin presenting to the emergency department to determine the prevalence of subclinical lead poisoning in intravenous methamphetamine users. Results: Mean blood leads for methamphetamine users (n = 92) were 6.22 μ g/dL or 0.30 μ mollL (range 0.10-1.15, SD 0.20) and 7.5μ g/dL or 0.35 μ nol/L (0.10-0.80, SD 0.15) for the nonmethamphetamine users (n = 53) with no significant difference between groups. Conclusions: The data suggest that previous outbreaks of acute intravenous lead poisoning among methamphetamine users were probably related to episodic contamination of methamphetamine. Subclinical lead poisoning was not found among the methamphetamine users presenting to the emergency department.

UR - http://www.scopus.com/inward/record.url?scp=0029682197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029682197&partnerID=8YFLogxK

U2 - 10.3109/15563659609013813

DO - 10.3109/15563659609013813

M3 - Article

VL - 34

SP - 425

EP - 430

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 4

ER -